Prospective randomised phase II trial evaluating adjuvant pelvic radiotherapy using either IMRT or 3-Dimensional planning for endometrial cancer

References

• Zhang S, Gong T-T, Liu F-H, et al. Global, regional, and national burden of endometrial cancer, 1990–2017: results from the global burden of disease study, 2017. Front Oncol. 2019;9:1440. doi: 10.3389/fonc.2019.01440.
   PubMed Web of Science ®Google Scholar
• Endometrial Cancer Statistics, World Cancer Research Fund International [Internet]. WCRF International. 2020 [cited 2022 Aug 1]. Available from: https://www.wcrf.org/cancer-trends/endometrial-cancer-statistics/
   Google Scholar
• NCRI_AnnualStatisticalReport_2022.pdf. [Internet]. 2022 [cited 2023 Feb 3]. Available from: https://www.ncri.ie/sites/ncri/files/pubs/NCRI_AnnualStatisticalReport_2022.pdf
   Google Scholar
• Factsheet corpus uteri.pdf [Internet]. 2020 [cited 2022 Aug 1]. Available from: https://www.ncri.ie/sites/ncri/files/factsheets/Factsheet%20corpus%20uteri.pdf.
   Google Scholar
• American Cancer Society, Cancer Facts & Statistics [Internet]. 2022 [cited 2022 Aug 1]. Available from: http://cancerstatisticscenter.cancer.org/
   Google Scholar
• Concin N, Matias-Guiu X, Vergote I, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31(1):12–39. doi: 10.1136/ijgc-2020-002230.
   PubMed Web of Science ®Google Scholar
• Creutzberg CL, Nout RA, Lybeert MLM, et al. Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma. Int J Radiat Oncol Biol Phys. 2011;81(4):e631–e638. doi: 10.1016/j.ijrobp.2011.04.013.
   PubMed Web of Science ®Google Scholar
• Kong A, Simera I, Collingwood M, et al. Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis. Ann Oncol. 2007;18(10):1595–1604. doi: 10.1093/annonc/mdm066.
   PubMed Web of Science ®Google Scholar
• de Boer SM, Powell ME, Mileshkin L, et al. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial. Lancet Oncol. 2019;20(9):1273–1285. doi: 10.1016/S1470-2045(19)30395-X.
   PubMed Web of Science ®Google Scholar
• Wortman BG, Creutzberg CL, Putter H, et al. Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy. Br J Cancer. 2018;119(9):1067–1074. doi: 10.1038/s41416-018-0310-8.
   PubMed Web of Science ®Google Scholar
• Sorbe B, Horvath G, Andersson H, et al. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma–a prospective randomized study. Int J Radiat Oncol Biol Phys. 2012;82(3):1249–1255. doi: 10.1016/j.ijrobp.2011.04.014.
   PubMed Web of Science ®Google Scholar
• Yang R, Xu S, Jiang W, et al. Dosimetric comparison of postoperative whole pelvic radiotherapy for endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy. Acta Oncol. 2010;49(2):230–236. doi: 10.3109/02841860903410372.
   PubMed Web of Science ®Google Scholar
• Heron DE, Gerszten K, Selvaraj RN, et al. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms. Gynecol Oncol. 2003;91(1):39–45. doi: 10.1016/s0090-8258(03)00461-x.
   PubMed Web of Science ®Google Scholar
• Mell LK, Mehrotra AK, Mundt AJ. Intensity-modulated radiation therapy use in the U.S., 2004. Cancer. 2005;104(6):1296–1303. doi: 10.1002/cncr.21284.
   PubMed Web of Science ®Google Scholar
• Lee SS, Weil CR, Boyd L, et al. Trends in IMRT utilization for definitive treatment of cervical cancer, 2004-2018. Int J Radiat Oncol Biol Phys. 2022;114(3):e342–e343. doi: 10.1016/j.ijrobp.2022.07.1438.
   Web of Science ®Google Scholar
• Mundt AJ, Lujan AE, Rotmensch J, et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2002;52(5):1330–1337. doi: 10.1016/s0360-3016(01)02785-7.
   PubMed Web of Science ®Google Scholar
• Barillot I, Tavernier E, Peignaux K, et al. Impact of post operative intensity modulated radiotherapy on acute gastro-intestinal toxicity for patients with endometrial cancer: results of the phase II RTCMIENDOMETRE french multicentre trial. Radiother Oncol. 2014;111(1):138–143. doi: 10.1016/j.radonc.2014.01.018.
   PubMed Web of Science ®Google Scholar
• Beriwal S, Jain SK, Heron DE, et al. Clinical outcome with adjuvant treatment of endometrial carcinoma using intensity-modulated radiation therapy. Gynecol Oncol. 2006;102(2):195–199. doi: 10.1016/j.ygyno.2006.01.062.
   PubMed Web of Science ®Google Scholar
• Roeske JC, Lujan A, Rotmensch J, et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2000;48(5):1613–1621. doi: 10.1016/s0360-3016(00)00771-9.
   PubMed Web of Science ®Google Scholar
• Portelance L, Chao KS, Grigsby PW, et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and Para-aortic irradiation. Int J Radiat Oncol Biol Phys. 2001;51(1):261–266. doi: 10.1016/s0360-3016(01)01664-9.
   PubMed Web of Science ®Google Scholar
• Mundt AJ, Mell LK, Roeske JC. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys. 2003;56(5):1354–1360. doi: 10.1016/s0360-3016(03)00325-0.
   PubMed Web of Science ®Google Scholar
• Chen C-C, Wang L, Lu C-H, et al. Comparison of clinical outcomes and toxicity in endometrial cancer patients treated with adjuvant intensity-modulated radiation therapy or conventional radiotherapy. J Formos Med Assoc. 2014;113(12):949–955. doi: 10.1016/j.jfma.2013.09.013.
   PubMed Web of Science ®Google Scholar
• Shih KK, Hajj C, Kollmeier M, et al. Impact of postoperative intensity-modulated radiation therapy (IMRT) on the rate of bowel obstruction in gynecologic malignancy. Gynecol Oncol. 2016;143(1):18–21. doi: 10.1016/j.ygyno.2016.07.116.
   PubMed Web of Science ®Google Scholar
• Jhingran A, Winter K, Portelance L, et al. A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418. Int J Radiat Oncol Biol Phys. 2012;84(1):e23–e28. doi: 10.1016/j.ijrobp.2012.02.044.
   PubMed Web of Science ®Google Scholar
• Ta M-H, Schernberg A, Giraud P, et al. Comparison of 3D conformal radiation therapy and intensity-modulated radiation therapy in patients with endometrial cancer: efficacy, safety and prognostic analysis. Acta Oncol. 2019;58(8):1127–1134. doi: 10.1080/0284186X.2019.1599136.
   PubMed Web of Science ®Google Scholar
• Klopp AH, Yeung AR, Deshmukh S, et al. Patient-Reported toxicity during pelvic Intensity-Modulated radiation therapy: NRG Oncology-RTOG 1203. J Clin Oncol. 2018;36(24):2538–2544. doi: 10.1200/JCO.2017.77.4273.
   PubMed Web of Science ®Google Scholar
• Yeung AR, Pugh SL, Klopp AH, et al. Improvement in Patient-Reported outcomes with Intensity-Modulated radiotherapy (RT) compared with standard RT: a report from the NRG oncology RTOG 1203 study. J Clin Oncol. 2020;38(15):1685–1692. doi: 10.1200/JCO.19.02381.
   PubMed Web of Science ®Google Scholar
• Small W, Mell LK, Anderson P, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys. 2008;71(2):428–434. doi: 10.1016/j.ijrobp.2007.09.042.
   PubMed Web of Science ®Google Scholar
• Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol Oncol. 2004;92(3):744–751. doi: 10.1016/j.ygyno.2003.11.048.
   PubMed Web of Science ®Google Scholar
• Cho LP, Cheng Z, McNutt TR, et al. Comparison of prospectively-collected genitourinary and gastrointestinal toxicities between post-operative intensity-modulated radiation therapy and non-intensity-modulated radiation therapy patients. Int J Radiat Oncol Biol Phys. 2017;99(2):E286–E287. doi: 10.1016/j.ijrobp.2017.06.1286.
   PubMed Web of Science ®Google Scholar
• Atkinson TM, Li Y, Coffey CW, et al. Reliability of adverse symptom event reporting by clinicians. Qual Life Res. 2012;21(7):1159–1164. doi: 10.1007/s11136-011-0031-4.
   PubMed Web of Science ®Google Scholar
• Basch E, Jia X, Heller G, et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst. 2009;101(23):1624–1632. doi: 10.1093/jnci/djp386.
   PubMedGoogle Scholar
• Yeung AR, Pugh S, Klopp AH, et al. IMRT improves late toxicity compared to conventional RT: an update on NRG oncology-RTOG 1203. Int J Radiat Oncol Biol Phys. 2019;105(1):S50. doi: 10.1016/j.ijrobp.2019.06.480.
   Web of Science ®Google Scholar
• He S, Gill BS, Heron DE, et al. Long-term outcomes using adjuvant pelvic intensity modulated radiation therapy (IMRT) for endometrial carcinoma. Pract Radiat Oncol. 2017;7(1):19–25. doi: 10.1016/j.prro.2016.06.005.
   PubMed Web of Science ®Google Scholar
• Soisson S, Ganz PA, Gaffney D, et al. Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study. Gynecol Oncol. 2018;148(3):499–506. doi: 10.1016/j.ygyno.2017.12.025.
   PubMed Web of Science ®Google Scholar
• Fred Hutch. High impact of positive and negative clinical trial results. [Internet]. 2019 [cited 2023 Mar 24]. Available from: https://www.fredhutch.org/en/news/spotlight/2019/10/phs_unger_jamanetopen.html.
   Google Scholar
• Laskar SG, Sinha S, Krishnatry R, et al. Access to radiation therapy: from local to global and equality to equity. J Clin Oncol Glob Oncol. 2022;8:e2100358. doi: 10.1200/GO.21.00358.
   Google Scholar